Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701350 · ClinicalTrials.gov registry record
Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes
A clinical trial of Preterm Birth and Intra-amniotic Infection, sponsored by ProteoGenix.
- Completed
- Registry status
- 79
- Enrollment target
- 4
- Study locations
NCT00701350: Completed study of Preterm Birth and Intra-amniotic Infection, sponsored by ProteoGenix.
NCT00701350 is a study of Preterm Birth and Intra-amniotic Infection that has completed, run by ProteoGenix. The registered enrollment target is 79 participants, below the 4,407-participant average among 39 other Preterm Birth trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00701350, a study of Preterm Birth and Intra-amniotic Infection, has completed, sponsored by ProteoGenix.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to investigate the expression of protein biomarkers in cervical vaginal fluid in women with preterm premature rupture of membranes (PPROM)
Conditions Studied
Study Locations (4)
Arizona
- Banner Good Samaritan Hospital - Phoenix
- Tucson Medical Center - Tucson
California
- Good Samaritan Hospital - San Jose
Colorado
- Presbyterian St. Luke's Medical Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-02 |
What the finished NCT00701350 record still lists
NCT00701350 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 4,407-participant average among 39 other Preterm Birth trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 0 interventions.
NCT00701350 reports a single indexed study location in Arizona, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT00701350 about?
NCT00701350 is a clinical study titled "Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes". The purpose of this study is to investigate the expression of protein biomarkers in cervical vaginal fluid in women with preterm premature rupture of membranes (PPROM)
What is the current status of trial NCT00701350?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2008-06. Estimated completion is 2010-02.
What conditions does trial NCT00701350 study?
This clinical trial studies the following conditions: Preterm Birth, Intra-amniotic Infection.
Who is sponsoring clinical trial NCT00701350?
This trial is sponsored by ProteoGenix, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00701350 being conducted?
This trial has 4 study locations across Arizona, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00701350's enrollment target sits among peer trials
79 29th of 39 higher than 11 of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia